During these difficult times, people in different areas around the world, are all contributing to combat the pandemic. We at Opharmic are doing everything we can to support fighting the virus.
 
While our operations and R&D activities are well on track thanks to technology, to ensure the safety and well-being of our team, we’re adopting a WFH + flexible office schedule in order for our staffs to minimise public contacts. In light of the recent stabilisation of low new case numbers in Hong Kong, our tentative date of return back to normal office hours is 4 May 2020. Should there be any changes in situation, this shall be revised accordingly.
 
To contribute in the recovery of our society post-pandemic, we are currently developing various measures and programmes including special vacancies for 2020 graduates. Should you have any questions regarding Opharmic, or ideas in how our company/ ultrasound technology may contribute to combating the pandemic, we welcome you to contact us for further discussion at info@opharmic.com.
 
Stay safe.
 
Image Source: H. GOV. [Online]. Available: https://www.coronavirus.gov.hk/eng/index.html.

​We’re proud to announce that effective from 29 Jan 2020 (after CNY), we will relocate to our brand-new 2000+ sq. ft office at Hong Kong Science Park to accommodate our growth. The new and larger office demonstrates our ever-expanding focus on technology research and development, in addition to supporting our needs in hardware product development.
 
Our office number will remain the same as +852 3703 5840. While mails sent to our old address remains temporarily available for a short period via redirection, we would appreciate if all our contacts can update our address to the following accordingly:
 
Unit 209, 2/F, Lakeside One
No.8 Science Park West Avenue
Hong Kong Science Park
Shatin, N.T., Hong Kong
 
Should you have any questions on the relocation, please feel free to contact us. We look forward to bringing more revolutionary medical innovation to patients and clinicians worldwide at our greatly improved office surroundings.

Four years ago, we were young graduates filling in our Incu-Bio application in a corner of a university computer barn, with a vision to bring our ultrasound ocular drug delivery innovation from bench to bedside.

From Sonikure to Opharmic, on 28 Dec 2019, the company officially graduated from the Hong Kong Science Park Incu-Bio Programme after an extremely rewarding journey. Below is a summary on what we’ve achieved:

• Gained 13 awards and recognitions
• Participated in 80+ local and international events
• Completed development of our first engineering prototype
• Further validated our technology in pre-clinical studies
• Received more than HK$4.5 million in funding support
• Raised our seed round of US$1.5 million
• And more…

 
Special thanks to Hong Kong Science & Technology Park and all their amazing teams for everything they’ve done. From hours after hours of investors introduction meetings, to that cold beer together after a day of fruitful event overseas.
 
Stay tuned for our graduation ceremony in 2020! It’s a brand-new page for us here at Opharmic, and we can only see unlimited opportunities and exciting challenges ahead of us.
 

  
​

Today we are thrilled to announce ​a new milestone toward our core value of being a holistic eye care platform!

Sonikure has rebranded as Opharmic.

What's New? 

We have moved our website to opharmic.com, where you can find out more about us. All our telephone lines remain unchanged. As for emails, all our Sonikure email remains temporarily active until further notice.